Who owns GENERATE BIOMEDICINES ORD?
- CUSIP Number: 370920100
Tip: Access positions for across all investors
Analyze quarterly positions in Generate Biomedicines Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Generate Biomedicines Ord stock
Who bought or sold GENERATE BIOMEDICINES ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Flagship Ventures Management | 63M | $783M | 100% | Mar 2026 |
|
| FMR | 4.2M | $53M | 100% | Mar 2026 |
|
| Capital World Investors | 4.0M | $50M | 100% | Mar 2026 |
|
| Braidwell | 3.6M | $45M | 100% | Mar 2026 |
|
| Arch Venture Corp | 1.9M | $24M | 100% | Mar 2026 |
|
| HarbourVest Partners | 1.7M | $22M | 100% | Mar 2026 |
|
| Baker Bros. Advisors | 1.4M | $18M | 100% | Mar 2026 |
|
| Harvard Management Company | 1.1M | $14M | 100% | Mar 2026 |
|
| Nvidia Corp | 833k | $10M | 100% | Mar 2026 |
|
| Alyeska Investment Group | 500k | $6.3M | 100% | Mar 2026 |
|
| ARK Investment Management | 498k | $6.2M | 100% | Mar 2026 |
|
| Millennium Management | 377k | $4.7M | 100% | Mar 2026 |
|
| UBS Group | 357k | $4.5M | 100% | Mar 2026 |
|
| Morgan Stanley | 337k | $4.2M | 100% | Mar 2026 |
|
| ExodusPoint Capital Management | 312k | $3.9M | 100% | Mar 2026 |
|
| CenterBook Partners | 267k | $3.3M | 100% | Mar 2026 |
|
| Sphera Funds Management | 185k | $2.3M | 100% | Mar 2026 |
|
| Goldman Sachs Group | 171k | $2.1M | 100% | Mar 2026 |
|
| Vanguard Capital Management | 131k | $1.6M | 100% | Mar 2026 |
|
| Seven Grand Managers | 125k | $1.6M | 100% | Mar 2026 |
|
| Jane Street | 123k | $1.5M | 100% | Mar 2026 |
|
| Geode Capital Management | 118k | $1.5M | 100% | Mar 2026 |
|
| LMR Partners | 100k | $1.3M | 100% | Mar 2026 |
|
| D. E. Shaw & Co | 95k | $1.2M | 100% | Mar 2026 |
|
| Ameriprise Financial | 87k | $1.1M | 100% | Mar 2026 |
|
| Balyasny Asset Management | 80k | $994k | 100% | Mar 2026 |
|
| Manufacturers Life Insurance Company | 74k | $929k | 100% | Mar 2026 |
|
| Barclays | 71k | $886k | 100% | Mar 2026 |
|
| Hrt Financial | 59k | $734k | 100% | Mar 2026 |
|
| TD Asset Management | 43k | $536k | 100% | Mar 2026 |
|
| Nikko Asset Management Americas | 40k | $500k | 100% | Mar 2026 |
|
| Sumitomo Mitsui Trust Holdings | 40k | $504k | 100% | Mar 2026 |
|
| Squarepoint Ops | 37k | $465k | 100% | Mar 2026 |
|
| Bank of America Corporation | 34k | $428k | 100% | Mar 2026 |
|
| Federated Investors | 30k | $375k | 100% | Mar 2026 |
|
| Tudor Investment Corporation | 24k | $298k | 100% | Mar 2026 |
|
| Davy Asset Management | 19k | $240k | 100% | Mar 2026 |
|
| Y-Intercept | 18k | $230k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 18k | $218k | 100% | Mar 2026 |
|
| Hudson Bay Capital Management | 17k | $209k | 100% | Mar 2026 |
|
| Brevan Howard Capital Management | 13k | $157k | 100% | Mar 2026 |
|
| Diametric Capital | 11k | $131k | 100% | Mar 2026 |
|
| Parallel Advisors | 5.6k | $69k | 100% | Mar 2026 |
|
| Albion Financial Group | 4.9k | $61k | 100% | Mar 2026 |
|
| FNY Investment Advisers | 3.0k | $37k | 100% | Mar 2026 |
|
| Citigroup | 2.2k | $28k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 1.2k | $15k | 100% | Mar 2026 |
|
| Wells Fargo & Company | 1.2k | $15k | 100% | Mar 2026 |
|
| Royal Bank of Canada | 231.00 | $3.0k | 100% | Mar 2026 |
|
| Efficient Wealth Management | 100.00 | $1.0k | 100% | Mar 2026 |
|